Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-κB activation cascade

Oncogene

Volumn 23, Issue 50, 2004, Pages 8282-8291

  Oh, Sang Muk ^a   Pyo, Chul Woong ^a   Kim, Youngho ^b   Choi, Sang Yun ^a  

^a Korea University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Lactoferrin; NF B; p53

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOFERRIN; PROTEIN P53; SYNAPTOTAGMIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; FIBROBLAST; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, P53; HUMANS; LACTOFERRIN; MICE; NEUTROPHILS; NF-KAPPA B; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

ANIMALIA; MAMMALIA;

EID: 8844263029     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208021     Document Type: Article

References (28)

1. Andrews NC and Faller DV. (1991). Nucleic Acids Res., 19, 2499.
2. Bagby Jr GC. (1989). Blood Cells, 15, 386-399.
3. Baud V and Karin M. (2001). Trends Cell Biol., 11, 372-377.
4. Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y and Karin M. (1999). Genes Dev., 13, 1297-1308.
5. El-Deiry WS. (1998). Semin. Cancer Biol., 8, 345-357.
6. Galbraith PR. (1986). Clin. Invest. Med., 9, 1-5.
7. Garre C, Bianchi-Scarra G, Sirito M, Musso M and Ravazzolo R. (1992). J. Cell. Physiol., 153, 477-482.
8. Ginsberg D, Oren M, Yaniv M and Piette J. (1990). Oncogene, 5, 1285-1290.
9. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
10. He J and Furmanski P. (1995). Nature, 373, 721-724.
11. Hellin AC, Calmant P, Gielen J, Bours V and Merville MP. (1998). Oncogene, 16, 1187-1195.
12. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. (1992). Cell, 71, 587-597.
13. Kirch HC, Flaswinkel S, Rumpf H, Brockmann D and Esche H. (1999). Oncogene, 18, 2728-2738.
14. Lee FS, Peters RT, Dang LC and Maniatis T. (1998). Proc. Natl. Acad. Sci. USA, 95, 9319-9324.
15. Levine AJ. (1997). Cell, 88, 323-331.
16. Li Q and Verma IM. (2002). Nat. Rev. Immunol., 2, 725-734.
17. Lin YZ, Yao SY, Veach RA, Torgerson TR and Hawiger J. (1995). J. Biol. Chem., 270, 14255-14258.
18. Ling L, Cao Z and Goeddel DV. (1998). Proc. Natl. Acad. Sci. USA, 95, 3792-3797.
19. Mikogami T, Heyman M, Spik G and Desjeux JF. (1994). Am. J. Physiol., 267, G308-G315.
20. Oh SM, Hahm DH, Kim IH and Choi SY. (2001). J. Biol. Chem., 276, 42575-42579.
21. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J and Sukumar S. (2000). Nature, 405, 974-978.
22. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z and Rothe M. (1997). Cell, 90, 373-383.
23. Schulze-Osthoff K, Ferrari D, Riehemann K and Wesselborg S. (1997). Immunobiology, 198, 35-49.
24. Shau H, Kim A and Golub SH. (1992). J. Leukocyte Biol., 51, 343-349.
25. Song HY, Regnier CH, Kirschning CJ, Goeddel DV and Rothe M. (1997). Proc. Natl. Acad. Sci. USA, 94, 9792-9796.
26. Suzuki YA and Lonnerdal B. (2002). Biochem. Cell Biol., 80, 75-80.
27. Weng H, Choi SY and Faller DV. (1995). J. Biol. Chem., 270, 13637-13644.
28. Zhao Q and Lee FS. (1999). J. Biol. Chem., 274, 8355-8358.